AptarGroup, Inc. (ATR) is a publicly traded Healthcare sector company. As of July 14, 2026, ATR trades at $124.82 with a market cap of $8.01B and a P/E ratio of 21.13. ATR moved -0.51% today. Year to date, ATR is +1.75%; over the trailing twelve months it is -20.91%. Its 52-week range spans $103.23 to $174.10. Analyst consensus is buy with an average price target of $138.00. Rallies surfaces ATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ATR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $124.82 |
| Market Cap | $8.01B |
| P/E Ratio | 21.13 |
| EPS | $5.91 |
| Dividend Yield | 0.48% |
| 52-Week High | $174.10 |
| 52-Week Low | $103.23 |
| Volume | 280.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.87B |
| Net Income | $386.60M |
| Gross Margin | 0.00% |
3 analysts cover ATR: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $138.00.